Cleavage of amyloid- precursor protein (APP) by ␣-, -, and ␥-secretases releases an extracellular fragment called APP S , small A peptides, and a short APP intracellular domain that may provide a transcriptional signal analogous to the Notch intracellular domain. Notch cleavage is activated by extracellular ligands on the cell surface, but the cellular localization of APP cleavage remains unclear. We now show that in transfected cultured cells, the plasma membrane SNARE protein syntaxin 1A, when expressed as a full-length protein, disrupts the Golgi apparatus and blocks transGolgi traffic and exocytosis. In contrast, truncated syntaxin 1A 1-243 selectively abolishes exocytosis but has no apparent effect on trans-Golgi traffic or Golgi structure, whereas further truncated syntaxins 1A and 1A 1-230 have no effect on either exocytosis or Golgi traffic. Using these syntaxin 1A fragments, we demonstrated that blocking trans-Golgi traffic greatly impairs APP cleavage and AICD-dependent nuclear signaling, whereas blocking exocytosis alone does not affect either process, even though secretion of APP S and A40 peptide is abolished. Our data suggest that, different from Notch, cleavage of APP is independent of cell surface regulation by extracellular ligands but may be controlled by intracellular signaling.
Amyloid- precursor protein (APP)1 of Alzheimer's disease is a ubiquitous membrane protein that is physiologically processed by site-specific proteolysis (1-4). First, cleavage of APP by ␣-or -secretases releases a large fragment called APP S that contains most of the extracellular sequences of APP. A small extracellular stub, the transmembrane region, and the cytoplasmic tail of APP (referred to as "AICD" for APP intracellular domain) remain in the membrane after ␣/-cleavage. These APP sequences are subsequently cleaved by ␥-secretase at multiple sites in the transmembrane region (5, 6). ␥-secretase cleavage results in the intracellular release of the AICD and the extracellular release of small peptides, including A40 and A42, the major components of amyloid fibrils in Alzheimer's disease (see reviews cited above).The processing pathway of APP resembles that of Notch, a cell surface protein that functions as a ligand-dependent regulator of cell fate (7,8). Notch exerts its regulatory effects by transcriptional activation of target genes, which is directly mediated by the released Notch intracellular domain (NICD). The cleavage of Notch that produces the NICD is probably performed by the same ␥-secretase complex that also generates the AICD of APP (7,8). Furthermore, the AICD may function as a transcriptional activator similar to the NICD (9), although it likely also has other signaling roles (10 -15). These similarities suggest that APP may be cleaved on the cell surface by a ligand-regulated mechanism, but the subcellular localization of APP cleavage has not been established. Extensive evidence suggests that ␣-and -secretases cleave APP after it has traversed the Golgi complex. For example, in cultured cell...